Edivoxetine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
OBJECTIVE
To identify symptoms potentially representative of a noradrenergic symptom cluster as possible predictors of response…
In this work, we discuss leveraging the Biopharmaceutics Classification System (BCS) in the development of edivoxetine HCl, a…
Introduction: The majority of available therapeutics to treat attention-deficit/hyperactivity disorder (ADHD) are formulations of…
This 12-month open-label, but dose-blinded extension phase,
evaluated the safety and tolerability of flexibly-dosed edivoxetine…
To assess the impact of hepatic or renal impairment on the pharmacokinetics (PK) of edivoxetine. Two separate multi-center, open…